BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Immune Design Corporation 

1102 Columbia Street
Suite 104
Seattle  Washington  98104  U.S.A.
Phone: n/a Fax: n/a


SEARCH JOBS




Industry
Biotechnology

Segment
Start Up





 Company News
Immune Design Corporation (IMDZ) Reports Fourth Quarter And Full Year 2014 Financial Results And Provides Corporate Update 4/1/2015 11:55:02 AM
Immune Design Corporation (IMDZ) Announces Positive Topline Data From Three Phase 1 Clinical Trials Of Immuno-Oncology Agents 4/1/2015 6:11:51 AM
Immune Design Corporation (IMDZ) Announces Treatment Of Patients With CMB305 Investigational Immuno-Oncology Agent 3/26/2015 6:53:16 AM
Immune Design Corporation (IMDZ) Announces Upcoming Financial Results And Immuno-oncology Conference Presentation 3/23/2015 9:29:39 AM
Immune Design Corporation (IMDZ) Appoints Lewis W. Coleman To Board Of Directors 3/19/2015 7:53:37 AM
Delaware Court Finds That THERAVECTYS Is Reasonably Likely To Succeed On The Merits Of Its Tortious Interference Claim Against Immune Design Corporation (IMDZ) 3/11/2015 11:22:57 AM
Immune Design Corporation (IMDZ) To Present At Upcoming Investment Conferences 2/24/2015 8:58:00 AM
Immune Design Corporation (IMDZ) Announces First Patients Dosed In Phase 1 Clinical Trial Of G100 Investigational Immuno-Oncology Agent 2/11/2015 7:33:14 AM
Immune Design Corporation (IMDZ) To Present At The 2015 Leerink Global Healthcare Conference 2/5/2015 1:34:33 PM
Immune Design Corporation (IMDZ) To Present At The 33rd Annual J.P. Morgan Healthcare Conference 1/8/2015 10:33:02 AM
12345